Vanta Bioscience Reports Turnaround to Profitability in H1 ended Sep'26
Vanta Bioscience Ltd 路 Outcome 路 14 Nov 2026, 12:36 am
Vanta Bioscience Reports Turnaround to Profitability in H1 ended Sep'26 Vanta Bioscience reported consolidated revenue from operations of Rs. 105.74 lakhs for the half year ended 30th Sep'26, up 250.36% YoY from Rs. 30.18 lakhs in the half year ended 30th Sep'25. Total revenue stood at Rs. 109.95 lakhs versus Rs. 30.18 lakhs YoY. The company posted a turnaround consolidated net profit of Rs. 5.14 lakhs compared to a net loss of Rs. 181.89 lakhs in the year-ago period. Basic and diluted EPS improved to Rs. 0.07 from a negative Rs. 2.56 YoY.
Original exchange filing (PDF)
More announcements from Vanta Bioscience Ltd
- Outcome of Board Meeting 路 14 Nov 2026
- Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... 路 13 Nov 2026
- Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... 路 13 Nov 2026
- Submission of AGM Proceedings, Voting Results and Scrutinizers Report for the 10th Annual General Meeting 路 01 Oct 2026
- Submission of AGM Proceedings, Voting Results and Scrutinizer''s Report for the 10th AGM 路 01 Oct 2026
- Outcome of Board Meeting held on 05.09.2026 - 10th AGM to be held on 30.09.2026 路 05 Sept 2026
- Audited standalone and consolidated Financial Results for the half year and financial year ended March 31, 2026 路 31 May 2026
- Outcome of the Board Meeting held on 30.05.2026 路 31 May 2026
